Novavax (NVAX) Short Interest Ratio & Short Volume → The Overlooked Retirement Asset You Probably Don’t Own (From Crypto 101 Media) (Ad) Free NVAX Stock Alerts $13.01 -1.39 (-9.65%) (As of 05/17/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Novavax Short Interest DataCurrent Short Volume44,930,000 sharesPrevious Short Volume43,770,000 sharesChange Vs. Previous Month+2.65%Dollar Volume Sold Short$194.55 millionShort Interest Ratio / Days to Cover6.6Last Record DateApril 30, 2024Outstanding Shares140,400,000 sharesPercentage of Shares Shorted32.00%Today's Trading Volume13,906,467 sharesAverage Trading Volume23,021,726 sharesToday's Volume Vs. Average60% Short Selling Novavax ? Sign up to receive the latest short interest report for Novavax and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatNVAX Short Interest Over TimeNVAX Days to Cover Over TimeNVAX Percentage of Float Shorted Over Time Ad True Market Insidersget a piece of the profit from this land This isn’t the prettiest land on earth. But it might be the most valuable. And you don’t have to own, lease, or rent any land.Click here to see my #1 investment for 2024. Novavax Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/202444,930,000 shares $194.55 million +2.7%N/A6.6 $4.33 4/15/202443,770,000 shares $180.33 million -0.3%N/A6.1 $4.12 3/31/202443,910,000 shares $209.89 million -8.8%N/A5.5 $4.78 3/15/202448,130,000 shares $254.61 million -8.7%N/A5.6 $5.29 2/29/202452,740,000 shares $260.54 million -3.8%N/A5.5 $4.94 2/15/202454,830,000 shares $235.77 million +5.3%N/A6.4 $4.30 Get the Latest News and Ratings for NVAX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Novavax and its competitors with MarketBeat's FREE daily newsletter. 1/31/202452,090,000 shares $208.36 million +2.3%N/A6.9 $4.00 1/15/202450,910,000 shares $233.17 million +3.5%N/A7 $4.58 12/31/202349,200,000 shares $236.16 million +8.0%N/A6.5 $4.80 12/15/202345,540,000 shares $245.92 million +5.6%N/A6 $5.40 11/30/202343,110,000 shares $237.11 million +4.8%N/A5.6 $5.50 11/15/202341,150,000 shares $255.13 million -8.4%N/A4.7 $6.20 10/31/202344,910,000 shares $299.10 million +4.5%N/A4.7 $6.66 10/15/202342,990,000 shares $303.08 million -3.3%N/A4.3 $7.05 9/30/202344,440,000 shares $321.75 million -0.1%N/A4.7 $7.24 9/15/202344,500,000 shares $343.10 million +11.0%N/A5 $7.71 8/31/202340,090,000 shares $320.72 million +0.7%N/A4.7 $8.00 8/15/202339,800,000 shares $288.15 million +7.7%N/A5.6 $7.24 7/31/202336,950,000 shares $342.90 million +0.7%N/A5.5 $9.28 7/15/202336,690,000 shares $318.47 million +0.7%N/A6.1 $8.68 6/30/202336,450,000 shares $270.82 million +18.2%N/A5.8 $7.43 6/15/202330,840,000 shares $248.57 million +2.7%N/A5.3 $8.06 5/31/202330,030,000 shares $241.74 million -6.0%N/A5.2 $8.05 5/15/202331,930,000 shares $258.95 million -5.0%N/A5 $8.11 4/30/202333,600,000 shares $257.71 million -1.6%N/A5.4 $7.67 4/15/202334,150,000 shares $312.81 million -9.6%N/A5.5 $9.16 3/31/202337,770,000 shares $261.75 million +13.6%N/A5.9 $6.93 3/15/202333,240,000 shares $196.12 million -2.6%N/A5 $5.90 2/28/202334,110,000 shares $315.86 million +6.4%N/A4.6 $9.26 2/15/202332,050,000 shares $326.59 million +3.9%N/A4.7 $10.19 1/31/202330,840,000 shares $336.46 million -0.2%N/A4.5 $10.91 1/15/202330,910,000 shares $379.88 million +1.6%N/A4.7 $12.29 12/30/202230,410,000 shares $312.61 million +24.3%N/A4.5 $10.28 12/15/202224,470,000 shares $277.00 million +3.8%N/A3.9 $11.32 11/30/202223,570,000 shares $388.67 million +4.4%N/A4.7 $16.49 11/15/202222,580,000 shares $524.31 million +0.6%N/A4.7 $23.22 10/31/202222,450,000 shares $499.96 million +5.1%N/A4.5 $22.27 10/15/202221,360,000 shares $420.15 million +9.5%N/A4 $19.67 9/30/202219,500,000 shares $354.90 million +14.6%N/A3.2 $18.20 9/15/202217,020,000 shares $554.00 million +9.0%N/A2.8 $32.55Elon to Transform U.S. Economy? (Ad)A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” grift of the elites. And yet, while it threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth.One company holds a near-total monopoly on it. NVAX Short Interest - Frequently Asked Questions What is Novavax's current short interest? Short interest is the volume of Novavax shares that have been sold short but have not yet been closed out or covered. As of April 30th, traders have sold 44,930,000 shares of NVAX short. Learn More on Novavax's current short interest. What is a good short interest ratio for Novavax? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. NVAX shares currently have a short interest ratio of 7.0. Learn More on Novavax's short interest ratio. Which institutional investors are shorting Novavax? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Novavax: Walleye Trading LLC, Ikarian Capital LLC, SG Americas Securities LLC, Capstone Investment Advisors LLC, BNP Paribas Financial Markets, IMC Chicago LLC, and Perceptive Advisors LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is Novavax's short interest increasing or decreasing? Novavax saw a increase in short interest in April. As of April 30th, there was short interest totaling 44,930,000 shares, an increase of 2.7% from the previous total of 43,770,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Novavax's short interest compare to its competitors? Here is how the short interest of companies in the industry of "biological products, except diagnostic" compare to Novavax: BioCryst Pharmaceuticals, Inc. (16.30%), Kodiak Sciences Inc. (3.76%), CRISPR Therapeutics AG (17.18%), Halozyme Therapeutics, Inc. (6.69%), Exelixis, Inc. (3.35%), Sana Biotechnology, Inc. (20.85%), Ginkgo Bioworks Holdings, Inc. (20.84%), Fusion Pharmaceuticals Inc. (4.64%), Beam Therapeutics Inc. (17.03%), Inhibrx, Inc. (4.18%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Novavax stock? Short selling NVAX is an investing strategy that aims to generate trading profit from Novavax as its price is falling. NVAX shares are trading down $1.39 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Novavax? A short squeeze for Novavax occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of NVAX, which in turn drives the price of the stock up even further. How often is Novavax's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including NVAX, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: BCRX Short Interest Data KOD Short Interest Data CRSP Short Interest Data HALO Short Interest Data EXEL Short Interest Data SANA Short Interest Data DNA Short Interest Data FUSN Short Interest Data BEAM Short Interest Data INBX Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:NVAX) was last updated on 5/19/2024 by MarketBeat.com Staff From Our PartnersBuy this small stock before coming AI Tidal WaveChaikin AnalyticsCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingDems have chosen Biden replacement?Paradigm PressForget Bitcoin: This $8 Stock Is the Next Big ThingBehind the MarketsShocking $16T Elon Musk Crypto LeakCrypto 101 MediaExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersA letter is coming from the "Bureau of the Fiscal Service".Stansberry ResearchHow Biden has already won 2024Porter & Company